Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why.
Revenue is growing, but the cannabis company still has a lot to prove to investors.
Canopy Growth Corporation (NASDAQ: CGC) reported a 13% increase in revenue for its fiscal 2027 first quarter, reaching $58.9 million. However, the stock market's reaction was minimal as investors have become wary of similar turnaround stories that haven't panned out. Despite these modest gains, the company's financial situation remains challenging.
Adjusted gross margin expanded from 25% to 31%, and adjusted EBITDA loss decreased by 59% to $2.3 million. Canadian medical cannabis revenue climbed 22%, while adult-use cannabis sales increased by 10%, and international cannabis sales grew by 10%. Nevertheless, Canopy Growth still does not achieve profitability, reporting a $10.6 million loss during the quarter, which ended on June 30.
Furthermore, the company's free cash outflow surged to $18.6 million, up from $8.4 million the previous year. This cash strain is concerning for a business that has been burdened by substantial cash burn, operational restructuring, and additional equity issuances to secure capital.
Written by urgent.news from Motley Fool's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
